Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Watchful Waiting | 4 | 2023 | 509 | 1.890 |
Why?
|
Prostatic Neoplasms | 17 | 2024 | 11324 | 1.300 |
Why?
|
Seminoma | 1 | 2023 | 134 | 0.790 |
Why?
|
Germ-Line Mutation | 3 | 2024 | 1843 | 0.740 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2023 | 493 | 0.740 |
Why?
|
Testicular Neoplasms | 2 | 2023 | 800 | 0.690 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2023 | 800 | 0.550 |
Why?
|
Venous Thrombosis | 2 | 2023 | 1293 | 0.500 |
Why?
|
Gene Amplification | 4 | 2012 | 1085 | 0.470 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2023 | 2277 | 0.450 |
Why?
|
Mexican Americans | 4 | 2007 | 163 | 0.410 |
Why?
|
Carcinoma, Renal Cell | 3 | 2024 | 3216 | 0.410 |
Why?
|
Prostate | 5 | 2023 | 1781 | 0.410 |
Why?
|
Genomics | 6 | 2023 | 5778 | 0.400 |
Why?
|
Genetic Testing | 5 | 2024 | 3531 | 0.390 |
Why?
|
Genome, Human | 4 | 2013 | 4412 | 0.360 |
Why?
|
Pharmacogenetics | 2 | 2012 | 680 | 0.320 |
Why?
|
Thrombosis | 1 | 2023 | 3042 | 0.320 |
Why?
|
Education, Medical | 2 | 2011 | 1726 | 0.310 |
Why?
|
Genetic Predisposition to Disease | 5 | 2024 | 17748 | 0.300 |
Why?
|
Clinical Medicine | 1 | 2009 | 145 | 0.300 |
Why?
|
Kidney Neoplasms | 2 | 2023 | 4312 | 0.300 |
Why?
|
Gene Dosage | 4 | 2009 | 1218 | 0.290 |
Why?
|
Disease Progression | 1 | 2023 | 13470 | 0.260 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2024 | 15750 | 0.260 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2013 | 3772 | 0.250 |
Why?
|
Prostatic Hyperplasia | 2 | 2020 | 526 | 0.240 |
Why?
|
Prostatectomy | 3 | 2023 | 1943 | 0.230 |
Why?
|
Learning | 1 | 2013 | 1729 | 0.230 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2012 | 2824 | 0.220 |
Why?
|
Homeodomain Proteins | 1 | 2012 | 2413 | 0.220 |
Why?
|
Prostate-Specific Antigen | 2 | 2023 | 2525 | 0.220 |
Why?
|
Curriculum | 2 | 2013 | 3710 | 0.210 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2804 | 0.200 |
Why?
|
Statistics as Topic | 1 | 2009 | 2364 | 0.200 |
Why?
|
Hematuria | 1 | 2023 | 233 | 0.200 |
Why?
|
Databases, Genetic | 1 | 2009 | 1740 | 0.200 |
Why?
|
Software | 3 | 2012 | 4421 | 0.190 |
Why?
|
DNA Copy Number Variations | 1 | 2009 | 2011 | 0.180 |
Why?
|
Asthma | 4 | 2007 | 6159 | 0.180 |
Why?
|
Linkage Disequilibrium | 1 | 2005 | 1995 | 0.180 |
Why?
|
Male | 28 | 2024 | 358602 | 0.180 |
Why?
|
Vena Cava, Inferior | 1 | 2023 | 458 | 0.170 |
Why?
|
Humans | 48 | 2024 | 759098 | 0.170 |
Why?
|
Patient-Centered Care | 1 | 2009 | 1414 | 0.160 |
Why?
|
Computational Biology | 3 | 2013 | 3505 | 0.160 |
Why?
|
Taxoids | 1 | 2022 | 668 | 0.160 |
Why?
|
Thrombectomy | 1 | 2023 | 707 | 0.150 |
Why?
|
Gene Expression Profiling | 10 | 2024 | 9372 | 0.150 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2019 | 189 | 0.150 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2017 | 70 | 0.150 |
Why?
|
Nephrectomy | 1 | 2023 | 1014 | 0.140 |
Why?
|
Gene Expression | 1 | 2009 | 7583 | 0.140 |
Why?
|
Transcription Factors | 2 | 2012 | 12106 | 0.120 |
Why?
|
Colorectal Neoplasms | 2 | 2012 | 6853 | 0.120 |
Why?
|
DNA, Neoplasm | 4 | 2013 | 1744 | 0.110 |
Why?
|
Biopsy | 2 | 2023 | 6770 | 0.110 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 92 | 0.110 |
Why?
|
Bronchodilator Agents | 3 | 2005 | 506 | 0.110 |
Why?
|
Retrospective Studies | 7 | 2023 | 80125 | 0.110 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2012 | 194 | 0.100 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4111 | 0.100 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2013 | 218 | 0.100 |
Why?
|
Genetic Markers | 3 | 2007 | 2607 | 0.100 |
Why?
|
Genes, Neoplasm | 1 | 2013 | 370 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1502 | 0.090 |
Why?
|
Risk Assessment | 2 | 2024 | 24049 | 0.090 |
Why?
|
E2F1 Transcription Factor | 1 | 2011 | 178 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2062 | 0.090 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 673 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2013 | 8489 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2023 | 14648 | 0.090 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2011 | 124 | 0.090 |
Why?
|
Estradiol | 1 | 2017 | 1931 | 0.090 |
Why?
|
Behavior | 1 | 2013 | 539 | 0.090 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39213 | 0.090 |
Why?
|
Puerto Rico | 3 | 2005 | 373 | 0.090 |
Why?
|
Comparative Genomic Hybridization | 4 | 2013 | 473 | 0.090 |
Why?
|
Estrogen Receptor alpha | 2 | 2017 | 580 | 0.080 |
Why?
|
Genotype | 6 | 2012 | 12940 | 0.080 |
Why?
|
DNA Methylation | 3 | 2020 | 4371 | 0.080 |
Why?
|
Ki-67 Antigen | 1 | 2011 | 631 | 0.080 |
Why?
|
DNA-Binding Proteins | 3 | 2011 | 9587 | 0.080 |
Why?
|
Aged | 7 | 2024 | 168615 | 0.080 |
Why?
|
Chromosome Aberrations | 3 | 2010 | 1772 | 0.080 |
Why?
|
Transcription, Genetic | 2 | 2021 | 7593 | 0.080 |
Why?
|
Genomic Instability | 2 | 2010 | 705 | 0.080 |
Why?
|
Risk Adjustment | 1 | 2012 | 601 | 0.080 |
Why?
|
GATA6 Transcription Factor | 1 | 2008 | 49 | 0.080 |
Why?
|
Epigenesis, Genetic | 2 | 2020 | 3754 | 0.080 |
Why?
|
Prognosis | 4 | 2024 | 29559 | 0.070 |
Why?
|
Cell Line, Tumor | 7 | 2013 | 16878 | 0.070 |
Why?
|
Sequence Deletion | 1 | 2011 | 1494 | 0.070 |
Why?
|
Middle Aged | 7 | 2024 | 219628 | 0.070 |
Why?
|
Testosterone | 1 | 2017 | 2468 | 0.070 |
Why?
|
Ticlopidine | 1 | 2012 | 895 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2023 | 21992 | 0.070 |
Why?
|
DNA Helicases | 1 | 2011 | 851 | 0.070 |
Why?
|
Biliary Tract Neoplasms | 1 | 2008 | 185 | 0.070 |
Why?
|
Chromosome Inversion | 1 | 2006 | 118 | 0.070 |
Why?
|
Stromal Cells | 2 | 2024 | 1326 | 0.060 |
Why?
|
Genetics, Population | 2 | 2012 | 924 | 0.060 |
Why?
|
Cell Survival | 2 | 2012 | 5793 | 0.060 |
Why?
|
Receptors, Androgen | 2 | 2021 | 1074 | 0.060 |
Why?
|
RNA Interference | 4 | 2017 | 2848 | 0.060 |
Why?
|
Emigration and Immigration | 1 | 2007 | 395 | 0.060 |
Why?
|
Prospective Studies | 3 | 2024 | 54190 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2009 | 5793 | 0.060 |
Why?
|
Endometrial Neoplasms | 1 | 2013 | 1362 | 0.060 |
Why?
|
Albuterol | 1 | 2004 | 212 | 0.060 |
Why?
|
Adenosine Triphosphatases | 1 | 2008 | 834 | 0.060 |
Why?
|
Warfarin | 1 | 2012 | 1516 | 0.060 |
Why?
|
Pancreatic Neoplasms | 2 | 2013 | 5312 | 0.050 |
Why?
|
Retroperitoneal Space | 1 | 2023 | 173 | 0.050 |
Why?
|
Antigens, Neoplasm | 1 | 2011 | 2000 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2009 | 2499 | 0.050 |
Why?
|
Anticoagulants | 2 | 2023 | 4896 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9271 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18391 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5690 | 0.050 |
Why?
|
Immunoglobulin E | 2 | 2005 | 1493 | 0.050 |
Why?
|
Metalloendopeptidases | 1 | 2003 | 394 | 0.050 |
Why?
|
Genome | 1 | 2009 | 1739 | 0.050 |
Why?
|
Multiprotein Complexes | 1 | 2008 | 1121 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11656 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2017 | 7838 | 0.050 |
Why?
|
BCG Vaccine | 1 | 2023 | 370 | 0.050 |
Why?
|
Soft Tissue Neoplasms | 1 | 2009 | 1151 | 0.050 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3812 | 0.040 |
Why?
|
Androgens | 1 | 2008 | 1287 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 257 | 0.040 |
Why?
|
Cohort Studies | 1 | 2023 | 41266 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 2005 | 1807 | 0.040 |
Why?
|
Pedigree | 1 | 2007 | 4572 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2012 | 3193 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 2897 | 0.040 |
Why?
|
Risk Factors | 2 | 2023 | 74167 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 3960 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13625 | 0.040 |
Why?
|
Tissue Array Analysis | 2 | 2011 | 550 | 0.040 |
Why?
|
RNA, Small Interfering | 3 | 2013 | 3443 | 0.040 |
Why?
|
Breast Neoplasms | 3 | 2010 | 21019 | 0.040 |
Why?
|
Aromatase | 1 | 2017 | 147 | 0.040 |
Why?
|
Lymph Node Excision | 1 | 2023 | 1304 | 0.040 |
Why?
|
Dihydrotestosterone | 1 | 2017 | 195 | 0.040 |
Why?
|
Genetic Variation | 1 | 2012 | 6531 | 0.030 |
Why?
|
Carcinoma | 1 | 2008 | 2335 | 0.030 |
Why?
|
Texas | 1 | 2017 | 401 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 4871 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5214 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 729 | 0.030 |
Why?
|
United States | 4 | 2021 | 72238 | 0.030 |
Why?
|
Signal Transduction | 4 | 2024 | 23328 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3616 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2247 | 0.030 |
Why?
|
Mutation | 2 | 2012 | 29878 | 0.030 |
Why?
|
Chromosome Mapping | 3 | 2008 | 4625 | 0.030 |
Why?
|
Epigenomics | 1 | 2020 | 935 | 0.030 |
Why?
|
Lung Neoplasms | 2 | 2009 | 13243 | 0.030 |
Why?
|
Glucose-6-Phosphatase | 1 | 2013 | 72 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2013 | 11046 | 0.030 |
Why?
|
Female | 10 | 2020 | 390174 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18094 | 0.030 |
Why?
|
Glycogen | 1 | 2013 | 251 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2017 | 1173 | 0.030 |
Why?
|
Sirolimus | 1 | 2020 | 1537 | 0.030 |
Why?
|
Mexico | 2 | 2005 | 755 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2347 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20027 | 0.030 |
Why?
|
Blotting, Western | 2 | 2009 | 5039 | 0.020 |
Why?
|
Phenotype | 2 | 2010 | 16524 | 0.020 |
Why?
|
Cluster Analysis | 2 | 2009 | 2698 | 0.020 |
Why?
|
Blood Coagulation Factors | 1 | 2013 | 366 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2925 | 0.020 |
Why?
|
Gene Library | 1 | 2013 | 1060 | 0.020 |
Why?
|
Search Engine | 1 | 2012 | 138 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2013 | 504 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2005 | 15815 | 0.020 |
Why?
|
Cell Proliferation | 3 | 2011 | 10427 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 3449 | 0.020 |
Why?
|
Transfection | 1 | 2017 | 5781 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4492 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1618 | 0.020 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2009 | 347 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10181 | 0.020 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2008 | 122 | 0.020 |
Why?
|
Gene Frequency | 2 | 2005 | 3603 | 0.020 |
Why?
|
Mice | 2 | 2012 | 80993 | 0.020 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2008 | 246 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2013 | 1152 | 0.020 |
Why?
|
Orchiectomy | 1 | 2009 | 470 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4523 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2011 | 635 | 0.020 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2008 | 375 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2008 | 419 | 0.020 |
Why?
|
Algorithms | 2 | 2021 | 13951 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13309 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8312 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5790 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4356 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15726 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2007 | 1304 | 0.020 |
Why?
|
Adipokines | 1 | 2008 | 311 | 0.020 |
Why?
|
Genes, BRCA1 | 1 | 2009 | 769 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2012 | 1402 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2008 | 748 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2814 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9274 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15262 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2008 | 1899 | 0.010 |
Why?
|
Alleles | 2 | 2005 | 6896 | 0.010 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2004 | 213 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3618 | 0.010 |
Why?
|
BRCA1 Protein | 1 | 2010 | 1146 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 22023 | 0.010 |
Why?
|
Animals | 2 | 2012 | 167531 | 0.010 |
Why?
|
Child | 3 | 2005 | 79604 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4715 | 0.010 |
Why?
|
Adolescent | 3 | 2005 | 87551 | 0.010 |
Why?
|
Oncogenes | 1 | 2008 | 1221 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18937 | 0.010 |
Why?
|
ADAM Proteins | 1 | 2003 | 240 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2009 | 1588 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9622 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15662 | 0.010 |
Why?
|
Aging | 1 | 2020 | 8633 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58864 | 0.010 |
Why?
|
Exons | 1 | 2006 | 2389 | 0.010 |
Why?
|
Glycoproteins | 1 | 2008 | 2202 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6070 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 2371 | 0.010 |
Why?
|
Cell Cycle | 1 | 2008 | 2936 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 2004 | 1685 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 25853 | 0.010 |
Why?
|
Cell Lineage | 1 | 2008 | 2522 | 0.010 |
Why?
|
Leukocytes | 1 | 2006 | 2030 | 0.010 |
Why?
|
Haplotypes | 1 | 2004 | 2761 | 0.010 |
Why?
|
Base Sequence | 1 | 2009 | 12442 | 0.010 |
Why?
|
Cell Movement | 1 | 2009 | 5196 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 4883 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20461 | 0.010 |
Why?
|
Regression Analysis | 1 | 2004 | 6358 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2008 | 4938 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2009 | 12765 | 0.010 |
Why?
|
Survival Rate | 1 | 2008 | 12793 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64867 | 0.010 |
Why?
|
Apoptosis | 1 | 2008 | 9470 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 9460 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5247 | 0.010 |
Why?
|
Adult | 1 | 2020 | 219353 | 0.000 |
Why?
|